Gwo-Yaw Ho
8PUBLICATIONS
78CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 27, 2024
Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer.Laura R Moffitt, Nazanin Karimnia, Amy L Wilson
|Nov 29, 2023
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.Gwo Yaw Ho, Cassandra J Vandenberg, Ratana Lim
|Oct 07, 2022
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.Gwo Yaw Ho, Elizabeth L Kyran, Justin Bedo
|Jul 29, 2021
Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma.Ksenija Nesic, Olga Kondrashova, Rachel M Hurley
|Mar 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.Christoph Grohmann, Francesca Walker, Mark Devlin
Pageof 2
Frequent Collaborators
5 joint publications
Matthew J Wakefield
3 joint publications
Clare L Scott
3 joint publications
Anna DeFazio
2 joint publications
Scott H Kaufmann
2 joint publications
Chin Wee Tan
2 joint publications
Olga Kondrashova
1 joint publications
Justin Bedo
1 joint publications
Hasan B Mirza
1 joint publications
Cassandra J Vandenberg
1 joint publications
Andrew Farrell